R. Borroni et al., Expression of GnRH receptor gene in human ectopic endometrial cells and inhibition of their proliferation by leuprolide acetate, MOL C ENDOC, 159(1-2), 2000, pp. 37-43
The present study was conducted to investigate whether GnRH-receptor (GnRH-
R) gene is expressed in endometriosis ovarian implants and whether a GnRH-a
nalogue (GnRH-a) may exert an effect on endometriosis cell proliferation in
vitro. The presence of GnRH-R transcripts in ovarian endometriosis cells w
as assessed by reverse transcription-polymerase chain reaction (RT-PCR) and
further confirmed by Southern blot analysis. GnRH-R mRNA was detected in a
ll the 13 samples examined. In contrast, GnRH-R transcripts were not detect
able in endometriosis-free peritoneal tissue. In the second part of the stu
dy, endometriosis cells were cultured for 9 days with different doses of le
uprolide acetate (ranging from 0 to 10(-5) M). In 4 out of 13 cases, a sign
ificant anti-proliferative effect was observed at doses of leuprolide aceta
te ranging from 10(-9) to 10(-5) M. In one case, a significant inhibition o
f cell proliferation was observed only at 10-5 M leuprolide acetate concent
ration. In contrast, the GnRH-a did not affect cell growth, regardless of t
he expression of GnRH-R transcripts and the given doses, in the remaining 8
experiments. To date, this is the first evidence indicating that GnRH-R mR
NA is expressed in human ovarian endometriomas. Moreover, the inhibition of
endometriosis cell proliferation induced by the GnRH-a in vitro suggests t
hat, at least in some cases, this compound might exert a direct effect on e
ndometriosis lesions. (C) 2000 Elsevier Science Ireland Ltd. All rights res
erved.